BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 16087912)

  • 1. The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis.
    Rupprecht TA; Pfister HW; Angele B; Kastenbauer S; Wilske B; Koedel U
    Neurology; 2005 Aug; 65(3):448-50. PubMed ID: 16087912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sublime diagnosis of Lyme neuroborreliosis.
    Segal BM; Logigian EL
    Neurology; 2005 Aug; 65(3):351-2. PubMed ID: 16087895
    [No Abstract]   [Full Text] [Related]  

  • 3. CSF B--lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis.
    Ljøstad U; Mygland A
    J Neurol; 2008 May; 255(5):732-7. PubMed ID: 18344056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New biomarker discovered. Will the diagnosis of neuroborreliosis soon be easier (interview by Maria Weiss)?].
    Rupprecht T
    MMW Fortschr Med; 2009 Apr; 151(18):8. PubMed ID: 19769063
    [No Abstract]   [Full Text] [Related]  

  • 5. Diagnostic performance of cerebrospinal fluid chemokine CXCL13 and antibodies to the C6-peptide in Lyme neuroborreliosis.
    Tjernberg I; Henningsson AJ; Eliasson I; Forsberg P; Ernerudh J
    J Infect; 2011 Feb; 62(2):149-58. PubMed ID: 21087629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment.
    Krumbholz M; Theil D; Cepok S; Hemmer B; Kivisäkk P; Ransohoff RM; Hofbauer M; Farina C; Derfuss T; Hartle C; Newcombe J; Hohlfeld R; Meinl E
    Brain; 2006 Jan; 129(Pt 1):200-11. PubMed ID: 16280350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study on the role of CXCL13 in Lyme neuroborreliosis.
    Schmidt C; Plate A; Angele B; Pfister HW; Wick M; Koedel U; Rupprecht TA
    Neurology; 2011 Mar; 76(12):1051-8. PubMed ID: 21422457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentration of interferon-inducible T cell chemoattractant and monocyte chemotactic protein-1 in serum and cerebrospinal fluid of patients with Lyme borreliosis.
    Grygorczuk S; Zajkowska J; Swierzbińska R; Pancewicz S; Kondrusik M; Hermanowska-Szpakowicz T
    Rocz Akad Med Bialymst; 2005; 50():173-8. PubMed ID: 16358960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relevance of immunological variables in neuroborreliosis and multiple sclerosis.
    Bednárová J; Stourac P; Adam P
    Acta Neurol Scand; 2005 Aug; 112(2):97-102. PubMed ID: 16008535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic difficulties in neuroborreliosis in children].
    Talarek E; Duszczyk E; Zarnowska H
    Przegl Epidemiol; 2007; 61(1):73-8. PubMed ID: 17702442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calprotectin levels in the cerebrospinal fluid reflect disease activity in multiple sclerosis.
    Berg-Hansen P; Vandvik B; Fagerhol M; Holmøy T
    J Neuroimmunol; 2009 Nov; 216(1-2):98-102. PubMed ID: 19800696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine CXCL13 concentration in cerebrospinal fluid in patients with neuroborreliosis--own observations.
    Kępa L; Oczko-Grzesik B; Sobala-Szczygieł B; Boroń-Kaczmarska A
    Przegl Epidemiol; 2015; 69(4):705-10, 851-5. PubMed ID: 27139348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCL13 chemokine in pediatric and adult neuroborreliosis.
    Wutte N; Berghold A; Löffler S; Zenz W; Daghofer E; Krainberger I; Kleinert G; Aberer E
    Acta Neurol Scand; 2011 Nov; 124(5):321-8. PubMed ID: 21320077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCL13 concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other neurological disorders determined by Luminex and ELISA.
    Markowicz M; Schötta AM; Kundi M; Bogovič P; Ogrinc K; Strle F; Stanek G
    Ticks Tick Borne Dis; 2018 Jul; 9(5):1137-1142. PubMed ID: 29705691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory diagnosis of Lyme neuroborreliosis is influenced by the test used: comparison of two ELISAs, immunoblot and CXCL13 testing.
    Wutte N; Archelos J; Crowe BA; Zenz W; Daghofer E; Fazekas F; Aberer E
    J Neurol Sci; 2014 Dec; 347(1-2):96-103. PubMed ID: 25288328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathecal Th17- and B cell-associated cytokine and chemokine responses in relation to clinical outcome in Lyme neuroborreliosis: a large retrospective study.
    Gyllemark P; Forsberg P; Ernerudh J; Henningsson AJ
    J Neuroinflammation; 2017 Feb; 14(1):27. PubMed ID: 28148307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCL13 as a diagnostic marker of neuroborreliosis and other neuroinflammatory disorders in an unselected group of patients.
    Wagner JN; Weis S; Kubasta C; Panholzer J; von Oertzen TJ
    J Neurol; 2018 Jan; 265(1):74-81. PubMed ID: 29134272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal Fluid B-lymphocyte Chemoattractant CXCL13 in the Diagnosis of Acute Lyme Neuroborreliosis in Children.
    Barstad B; Tveitnes D; Noraas S; Selvik Ask I; Saeed M; Bosse F; Vigemyr G; Huber I; Øymar K
    Pediatr Infect Dis J; 2017 Dec; 36(12):e286-e292. PubMed ID: 28661964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid chemokine CXCL13 in the diagnosis of neuroborreliosis in children.
    Sillanpää H; Skogman BH; Sarvas H; Seppälä IJ; Lahdenne P
    Scand J Infect Dis; 2013 Jul; 45(7):526-30. PubMed ID: 23521134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of CXCL8, CXCL10, CXCL11, CXCL12 and CXCL13 in serum and cerebrospinal fluid of patients with neuroborreliosis.
    Moniuszko A; Czupryna P; Pancewicz S; Rutkowski K; Zajkowska O; Swierzbińska R; Grygorczuk S; Kondrusik M; Owłasiuk P; Zajkowska J
    Immunol Lett; 2014; 157(1-2):45-50. PubMed ID: 24239846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.